Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IHEEZO vs Routine Anesthesia for Intravitreal Injections (QUELL)
NCT07456826Phase 4Enrolling by invitation
- Sponsor
- Harrow
- Start
- Mar 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of chloroprocaine hydrochloride (2 arms), sponsored by Harrow. Primary endpoint: Proportion of Participants Achieving Successful Ocular Surface Anesthesia. Started Mar 2026; status: enrolling by invitation.
02
Drugs
chloroprocaine hydrochloride
Beyond the preview
Go deeper on NCT07456826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07456826.